Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Dyskinesia, Medication-Induced

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Dyskinesia, Medication-Induced in 2 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mango, D1
Bonito-Oliva, A1
Ledonne, A1
Cappellacci, L1
Petrelli, R1
Nisticò, R1
Berretta, N1
Fisone, G1
Mercuri, NB1
Varty, GB1
Hodgson, RA1
Pond, AJ1
Grzelak, ME1
Parker, EM1
Hunter, JC1

Other Studies

2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Dyskinesia, Medication-Induced

ArticleYear
Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice.
    Experimental neurology, 2014, Volume: 261

    Topics: Action Potentials; Age Factors; Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Anim

2014
The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
    Psychopharmacology, 2008, Volume: 200, Issue:3

    Topics: Adenosine A2 Receptor Antagonists; Animals; Antipsychotic Agents; Caffeine; Catalepsy; Cebus; Corpus

2008